Tiba Aynechi
Angel · California
Board director at 4 startups that filed Form D raises since late 2024, mostly in California.
- Stages
- Series B, Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Aug 2025
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Spruce BiosciencesFeb 28, 2023
- SEC Form D: Ray TherapeuticsMay 26, 2023
- SEC Form D: Avalyn PharmaOct 10, 2023
- SEC Form D: Rezo TherapeuticsAug 18, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.